Novel virtual lead identification in the discovery of hematopoietic cell kinase (HCK) inhibitors: application of 3D QSAR and molecular dynamics simulation

References

• Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002;298:1912–34.
   PubMed Web of Science ®Google Scholar
• Kim LC, Song L, Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 2009;6:587–95.
   PubMed Web of Science ®Google Scholar
• Sicheri F, Moarefi I, Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature 1997;385:602–9.
   PubMed Web of Science ®Google Scholar
• Silverman L, Sudol M, Resh MD. Members of the src family of nonreceptor tyrosine kinases share a common mechanism for membrane binding. Cell Growth Differ 1993;4:475–82.
   PubMedGoogle Scholar
• Robbins SM, Quintrell NA, Bishop JM. Myristoylation and differential palmitoylation of the Hck protein-tyrosine kinases govern their attachment to membranes and association with caveolae. Mol Cell Biol 1995;15:3507–15.
   PubMed Web of Science ®Google Scholar
• Roskoski R. Jr., Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 2004;324:1155–64.
   PubMed Web of Science ®Google Scholar
• Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene 2004;23:7918–27.
   PubMed Web of Science ®Google Scholar
• Willman CL, Stewart CC, Longacre TL, et al. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages. Blood 1991;77:726–34.
   PubMed Web of Science ®Google Scholar
• Carreno S, Caron E, Cougoule C, et al. p59Hck isoform induces F-actin reorganization to form protrusions of the plasma membrane in a Cdc42- and Rac-dependent manner. J Biol Chem 2002;277:21007–16.
   PubMed Web of Science ®Google Scholar
• Danhauser-Riedl S, Warmuth M, Druker BJ, et al. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Cancer Res 1996;56:3589–96.
   PubMed Web of Science ®Google Scholar
• Lionberger JM, Wilson MB, Smithgall TE. Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck. J Biol Chem 2000;275:18581–5.
   PubMed Web of Science ®Google Scholar
• Stanglmaier M, Warmuth M, Kleinlein I, et al. The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains. Leukemia 2003;17:283–9.
   PubMed Web of Science ®Google Scholar
• Klejman A, Schreiner SJ, Nieborowska-Skorska M, et al. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. Embo J 2002;21:5766–74.
   PubMed Web of Science ®Google Scholar
• Guiet R, Poincloux R, Castandet J, et al. Hematopoietic cell kinase (Hck) isoforms and phagocyte duties - from signaling and actin reorganization to migration and phagocytosis. Eur J Cell Biol 2008;87:527–42.
   PubMed Web of Science ®Google Scholar
• Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000;96:3343–56.
   PubMed Web of Science ®Google Scholar
• Warmuth M, Bergmann M, Priess A, et al. The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr. J Biol Chem 1997;272:33260–70.
   PubMed Web of Science ®Google Scholar
• Stephen AG, Esposito D, Bagni RK, et al. Dragging ras back in the ring. Cancer Cell 2014;25:272–81.
   PubMed Web of Science ®Google Scholar
• Goldman JM. How I treat chronic myeloid leukemia in the imatinib era. Blood 2007;110:2828–37.
   PubMed Web of Science ®Google Scholar
• Martinelli G, Soverini S, Rosti G, et al. New tyrosine kinase inhibitors in chronic myeloid leukemia. Haematologica 2005;90:534–41.
   PubMed Web of Science ®Google Scholar
• Weisberg E, Manley PW, Cowan-Jacob SW, et al. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer 2007;7:345–56.
   PubMed Web of Science ®Google Scholar
• Nazari-Shafti TZ, Freisinger E, Roy U, et al. Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection. Retrovirology 2011;8:3.
   PubMed Web of Science ®Google Scholar
• Briggs SD, Sharkey M, Stevenson M, et al. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J Biol Chem 1997;272:17899–902.
   PubMed Web of Science ®Google Scholar
• Emert-Sedlak L, Kodama T, Lerner EC, et al. Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds. ACS Chem Biol 2009;4:939–47.
   PubMed Web of Science ®Google Scholar
• Ranjitkar P, Brock AM, Maly DJ. Affinity reagents that target a specific inactive form of protein kinases. Chem Biol 2010;17:195–206.
   PubMed Web of Science ®Google Scholar
• Davis MI, Hunt JP, Herrgard S, et al. Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 2011;29:1046–51.
   PubMed Web of Science ®Google Scholar
• Kurogi Y, Guner OF. Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. Curr Med Chem 2001;8:1035–55.
   PubMed Web of Science ®Google Scholar
• Debnath AK. Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase. J Med Chem 2002;45:41–53.
   PubMed Web of Science ®Google Scholar
• Lu IL, Tsai KC, Chiang YK, et al. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors. Eur J Med Chem 2008;43:1603–11.
   PubMed Web of Science ®Google Scholar
• Fischer R. The principle of experimentation illustrated by a psycho-physical expe, Chapter II, 8th ed. New York: Hafner Publishing Co; 1966.
   Google Scholar
• John S, Thangapandian S, Arooj M, et al. Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors. BMC Bioinformatics 2011;12 Suppl:S4.
   Google Scholar
• Kumar R, Son M, Bavi R, et al. Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling. Acta Pharmacol Sin 2015;36:998–1012.
   PubMed Web of Science ®Google Scholar
• Steindl T, Langer T. Influenza virus neuraminidase inhibitors: generation and comparison of structure-based and common feature pharmacophore hypotheses and their application in virtual screening. J Chem Inf Comput Sci 2004;44:1849–56.
   PubMedGoogle Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727–48.
   PubMed Web of Science ®Google Scholar
• Sabat M, VanRens JC, Laufersweiler MJ, et al. The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck). Bioorg Med Chem Lett 2006;16:5973–7.
   PubMed Web of Science ®Google Scholar
• Van Der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem 2005;26:1701–18.
   PubMed Web of Science ®Google Scholar
• Zoete V, Cuendet MA, Grosdidier A, et al. SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 2011;32:2359–68.
   PubMed Web of Science ®Google Scholar
• Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys 2007;126:014101.
   PubMed Web of Science ®Google Scholar
• Parrinello M, Rahman A. Polymorphic transitions in single crystals. A new molecular dynamics method. J Appl Phys 1981;52:7182.
   Web of Science ®Google Scholar
• Hess B, Bekker H, Berendsen HJC, et al. LINCS: a linear constraint solver for molecular simulations. J Comput Chem 1997;18:1463–1472.
   Web of Science ®Google Scholar
• Miyamoto S, Kollman PA. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 2004;13:952–962.
   Web of Science ®Google Scholar
• Darden T, York D, Pedersen L. Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089–10092.
   Web of Science ®Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33–38.
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Li Y, et al. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 2011;51:69–82.
   PubMed Web of Science ®Google Scholar
• Spiliotopoulos D, Spitaleri A, Musco G. Exploring PHD fingers and H3K4me0 interactions with molecular dynamics simulations and binding free energy calculations: AIRE-PHD1, a comparative study. PLoS One 2012;7:e46902.
   Google Scholar
• Bavi R, Kumar R, Choi L, et al. Exploration of novel inhibitors for Bruton's tyrosine kinase by 3D QSAR modeling and molecular dynamics simulation. PLoS One 2016;11:e0147190.
   Google Scholar
• Bavi R, Kumar R, Rampogu S, et al. Molecular interactions of UvrB Protein and DNA from Helicobacter pylori: insight into a molecular modeling approach. Comput Biol Med 2016;75:181–189.
   PubMed Web of Science ®Google Scholar
• Homeyer N, Gohlke H. Free energy calculations by the molecular mechanics poisson boltzmann surface area method. Mol Inf 2012;31:114–122.
   PubMed Web of Science ®Google Scholar
• Eldridge MD, Murray CW, Auton TR, et al. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des 1997;11:425–45.
   PubMed Web of Science ®Google Scholar
• Hartshorn MJ, Verdonk ML, Chessari G, et al. Diverse, high-quality test set for the validation of protein-ligand docking performance. J Med Chem 2007;50:726–41.
   PubMed Web of Science ®Google Scholar
• Wang Y, Suzek T, Zhang J, et al. PubChem BioAssay: 2014 update. Nucleic Acids Res 2014;42:D1075–82.
   Google Scholar
• Bonnet P, Bryce RA. Molecular dynamics and free energy analysis of neuraminidase-ligand interactions. Protein Sci 2004;13:946–57.
   PubMed Web of Science ®Google Scholar
• Donini OA, Kollman PA. Calculation and prediction of binding free energies for the matrix metalloproteinases. J Med Chem 2000;43:4180–8.
   PubMed Web of Science ®Google Scholar